Sort
64,565 grants matching “drug discovery”
Discovery of novel flavivirus inhibitors
$2,677,020Fumiaki Yokokawa · University Of Texas Med Br Galveston · U19 · FY2022 · AI
Comprehensive Cancer Center Program at Fox Chase
$2,675,570Richard I Fisher · Research Inst Of Fox Chase Can Ctr · P30 · FY2016 · CA
Structure-function relationships in alpha-synuclein strain biology
$2,674,385Amanda L. Woerman · Colorado State University · RF1 · FY2025 · NS
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk
$2,673,849John Blangero · Texas Biomedical Research Institute · R01 · FY2014 · HL
Intercollaborative Radiation Countermeasure (INTERACT) Consortium for Advanced Development of Medical Countermeasures to Mitigate/Treat Acute and Delayed Radiation Syndromes
$2,669,672Isabel Lauren Jackson · University Of Maryland Baltimore · U19 · FY2021 · AI
FAMU RCMI Pharmaceutical Research Center
$2,669,457Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2015 · MD
Implantable, Degradable Drug Delivery Devices for Non-Opioid Post-Surgical Pain Management
$2,668,301Kelly Anne Burke · University Of Connecticut Storrs · R18 · FY2025 · EB
Asthma Inflammation Research
$2,667,320Serpil C. Erzurum · Cleveland Clinic Lerner Com-Cwru · P01 · FY2016 · HL
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$2,664,477Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2009 · RR
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$2,664,477Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2009 · RR
Pharmacogenomics of Arrhythmia Therapy
$2,658,629Dan M Roden · Vanderbilt University · U01 · FY2008 · HL
Moffitt Cancer Center Support Grant
$2,657,144William S. Dalton · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2011 · CA
A Neural Systems Approach to Monitoring and Drug-Delivery for General Anesthesia
$2,654,750Patrick L. Purdon · Massachusetts General Hospital · DP2 · FY2009 · OD
NCI-Frederick Support and Technical Services
$2,653,485Kristin Komschlies McConville · Office Of The Director, Nci · ZIC · FY2023 · CA
Scientific Core - Compound Optimization and Prioritization.
$2,652,211Anna Upton · Global Alliance For Tb Drug Development · U19 · FY2021 · AI
Center of Catalytic Bioscanvenger Medical Defense Research II: Discovery, Formula
$2,650,595Douglas Mark Cerasoli · U.S. Army Medical Research Inst Chem Def · U54 · FY2011 · NS
Pharmacogenomics of Arrhythmia Therapy
$2,647,864Dan M Roden · Vanderbilt University · U01 · FY2006 · HL
Preclinical studies for the development of selective mGlu2 positive allosteric modulators to treat substance use disorders
$2,646,217Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2017 · DA
3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery
$2,644,877Marc Ferrer-Alegre · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
The Vanderbilt Specialized Chemistry Center for Accelerated Probe Development
$2,644,617Craig Lindsley · Vanderbilt University · U54 · FY2013 · MH
Pharmacogenomics of Arrhythmia Therapy
$2,644,284Dan M Roden · Vanderbilt University · U01 · FY2007 · HL
iPSC-based platform development for major psychiatric disorder modeling and discovery
$2,643,131Hongjun Song · University Of Pennsylvania · U19 · FY2017 · MH
The I SPY 2.2 TRIAL: Evolving to Imaging and Molecular Biomarker Response Directed Adaptive Sequential Treatment to Optimize Breast Cancer Outcomes
$2,641,849Laura J Esserman · University Of California, San Francisco · P01 · FY2024 · CA
Genetic variant-based drug discovery targeting conserved pathways of aging
$2,640,750Jan No Middle Name Vijg · Albert Einstein College Of Medicine · U19 · FY2025 · AG
Host Pathogen Variation & TB Pathogenesis
$2,638,886Thomas R Hawn · University Of Washington · U19 · FY2021 · AI